618
Views
1
CrossRef citations to date
0
Altmetric
Review

Therapeutic applications and pharmacoeconomics of microneedle technology

, ORCID Icon, , & ORCID Icon
Pages 359-369 | Received 18 Apr 2018, Accepted 03 Jun 2018, Published online: 14 Jun 2018

References

  • Chiarello K. Breaking the barrier: advances in transdermal technology. Pharm Tech. 2004;28:46–56.
  • Prausnitz MR. Microneedles for transdermal drug delivery. Adv Drug Delivery Rev. 2004;56:581–587.
  • BusinessWire. Global transdermal drug delivery market worth USD 95.57 billion by 2025 - analysis, technologies & forecasts report 2016–2025. [cited 2018 Apr]. Available from: https://www.businesswire.com/news/home/20161111005701/en/Global-Transdermal-Drug-Delivery-Market-Worth-USD
  • Indermun S, Luttge R, Choonara YE, et al. Current advances in the fabrication of microneedles for transdermal delivery. J Control Release. 2014;185:130–138.
  • Henry S, McAllister DV, Allen MG, et al. Microfabricated microneedles: a novel approach to transdermal drug delivery. J Pharm Sci. 1998;87(8):922–925.
  • Wermeling D, Banks S, Hudson D, et al. Microneedles permit transdermal delivery of a skin-impermeant medication to humans. PNAS. 2008;105(6):2058–2063.
  • Bariya SH, Gohel MC, Mehta TA, et al. Microneedles: an emerging transdermal drug delivery system. J Pharm Pharmacol. 2012;64:11–29.
  • Sivaraman A, Banga AK. Novel in situ forming hydrogel microneedles for transdermal drug delivery. Drug Delivery Transl Res. 2017;7:16–26.
  • Kim YC, Park JH, Prausnitz M. Microneedles for drug and vaccine delivery. Adv Drug Delivery Rev. 2012;64:1547–1568.
  • Donnelly RF, Singh TRR, Woolfson AD. Microneedle-based drug delivery systems: microfabrication, drug delivery, and safety. Drug Delivery. 2010;17:187–207.
  • Vieira MG, da Silva MA, dos Santos LO, et al. Natural-based plasticizers and biopolymer films: a review. Eur Polym J. 2011;47(3):254–263.
  • Bhatnagar S, Dave K, Venugantia VVK. Microneedles in the clinic. J Controlled Release. 2017;260:164–182.
  • Cheung K, Das DB. Microneedles for drug delivery: trends and progress. Drug Delivery. 2016;23(7):2338–2354.
  • Ma G, Wu C. Microneedle, bio-microneedle and bio-inspired microneedle: a review. J Controlled Release. 2017;251:11–23.
  • Ling MH, Chen MC. Dissolving polymer microneedle patches for rapid and efficient transdermal delivery of insulin to diabetic rats. Acta Biomater. 2013;9:8952–8961.
  • Benson HAE, Namjoshi S. Proteins and peptides: strategies for delivery to and across the skin. J Pharm Sci. 2008;97:3591–3610.
  • Kochhar JS, Zou S, Chan SY, et al. Protein encapsulation in polymeric microneedles by photolithography. Int J Nanomed. 2012;7:3143–3154.
  • Edens C, Collins ML, Ayers J, et al. Measles vaccination using a microneedle patch. Vaccine. 2013;31:3403–3409.
  • Torrisi BM, Zarnitsyn V, Prausnitz MR, et al. Pocketed microneedles for rapid delivery of a liquid-state botulinum toxin A. J Control Release. 2013;165:146–152.
  • Morefield GL, Tammariello RF, Purcell BK, et al. An alternative approach to combination vaccines: intradermal administration of isolated components for control of anthrax, botulism, plague and staphylococcal toxic shock. J Immune Based Ther Vaccines. 2008;6:5–11.
  • Hirschberg HJ, van de Wijdeven GG, Kraan H, et al. Bioneedles as alternative delivery system for hepatitis B vaccine. J Control Release. 2010;147:211–217.
  • Laurent PE, Bourhy H, Fantino M, et al. Safety and efficacy of novel dermal and epidermal microneedle delivery systems for rabies vaccination in healthy adults. Vaccine. 2010;28:5850–5856.
  • Zhang S, Qin G, Wu Y, et al. Enhanced bioavailability of L-carnitine after painless intradermal delivery vs. oral administration in rats. Pharm Res. 2011;28:117–123.
  • Fukushima K, Ise A, Morita H, et al. Two-layered dissolving microneedles for percutaneous delivery of peptide/protein drugs in rats. Pharm Res. 2011;28:7–21.
  • Ito Y, Yoshimitsu J, Shiroyama K, et al. Self-dissolving microneedles for the percutaneous absorption of EPO in mice. J Drug Target. 2006;14:255–261.
  • Gupta J, Park SS, Bondy B, et al. Infusion pressure and pain during microneedle injection into skin of human subjects. Biomaterials. 2011;32:6823–6831.
  • Norman JJ, Brown MR, Raviele NA, et al. Faster pharmacokinetics and increased patient acceptance of intradermal insulin delivery using a single hollow microneedle in children and adolescents with type 1 diabetes. Pediatr Diabetes. 2013;14(6):459–465.
  • Cormier M, Johnson B, Ameri M, et al. Transdermal delivery of desmopressin using a coated microneedle array system. J Controlled Release. 2004;97:503–511.
  • Daddona PE, Matriano JA, Mandema J, et al. Parathyroid hormone (1–34)-coated microneedle patch system: clinical pharmacokinetics and pharmacodynamics for treatment of osteoporosis. Pharm Res. 2011;28:159–165.
  • Macedo CG, Jain AK, Franz-Montan M, et al. Microneedles enhance topical delivery of 15-deoxy-Δ12,14-prostaglandin J2 and reduce nociception in temporomandibular joint of rats. J Control Release. 2017;265:22–29.
  • Li X, Zhao R, Qin Z, et al. Microneedle pretreatment improves efficacy of cutaneous topical anesthesia. Am J Emerg Med. 2010;28(2):130–134.
  • Park JH, Allen MG, Prausnitz MR. Biodegradable polymer microneedles: fabrication, mechanics and transdermal drug delivery. J Control Release. 2005;104:51–66.
  • Qiu Y, Gao Y, Hu K, et al. Enhancement of skin permeation of docetaxel: a novel approach combining microneedle and elastic liposomes. J Control Release. 2008;129:144–150.
  • Jiang J, Gill HS, Ghate D, et al. Coated microneedles for drug delivery to the eye. Invest Oph-Thalmol Vis Sci. 2007;48:4038–4043.
  • Gill HS, Prausnitz MR. Coated formulations for microneedles. Pharm Res. 2007;24:1369–1380.
  • Sivamani RK, Liepmann D, Maibach HI. Microneedles and transdermal applications. Exp Op Drug Delivery. 2007;4:19–25.
  • Davis SP, Landis BJ, Adams ZH. Insertion of microneedles into skin: measurement and prediction of insertion force and needle fracture force. J Biomech. 2004;37:1155–1163.
  • Donnelly R, Douroumis D. Microneedles for drug and vaccine delivery and patient monitoring. Drug Delivery Transl Res. 2015;5(4):311–312.
  • Dogra S, Yadav S, Sarangal R. Microneedling for acne scars in Asian skin type: an effective low-cost treatment modality. J Cosmet Dermatol. 2014;13:180–187.
  • Lee YB, Eun YS, Lee JH, et al. Effects of topical application of growth factors followed by microneedle therapy in women with female pattern hair loss: a pilot study. J Dermatol. 2013;40:81–83.
  • Larrañeta E, Lutton R, Woolfson D, et al. Microneedle arrays as transdermal and intradermal drug delivery systems: materials science, manufacture and commercial development. Mater Sci Eng. 2016;104:1–32.
  • Ogundele M, Okafor HK. Transdermal drug delivery: microneedles, their fabrication and current trends in delivery methods. J Pharm Res Int. 2017;18(5):1–14.
  • LTS Lohman website. [cited 2018 May]. Available from: https://ltslohmann.de/en/technology/transdermal-therapeutic-systems/
  • Corium website. Manufacturing: from concept to commercialization. [cited 2018 May]. Available from: http://www.coriumintl.com/
  • Jina A, Tierney MJ, Tamada JA, et al. Development, and evaluation of a novel microneedle array-based continuous glucose monitor. J Diabetes Sci Technol. 2014;8(3):483–487.
  • Bal SM, Caussin J, Pavel S, et al. In vivo assessment of safety of microneedle arrays in human skin. Eur J Pharm Sci. 2008;35(3):193–202.
  • Rouphael NG, Paine M, Mosley R, et al. The safety, immunogenicity, and acceptability of inactivated influenza vaccine delivered by microneedle patch (TIV-MNP 2015): a randomised, partly blinded, placebo-controlled, phase 1 trial. Lancet. 2017;390(10095):649–658.
  • Vicente-Perez E, Larrañeta E, McCrudden MTC, et al. Repeat application of microneedles does not alter skin appearance or barrier function and causes no measurable disturbance of serum biomarkers of infection, inflammation or immunity in mice in vivo. Eur J Pharm Biopharm. 2017;117:400–407.
  • Al-Zahrani S, Zaric M, McCrudden C, et al. Microneedle mediated vaccine delivery: harnessing cutaneous immunobiology to improve efficacy. Expert Opin Drug Deliv. 2012;9:541–550.
  • Prausnitz MR, Mitragoti S, Langer R. Current status and future potential of transdermal drug delivery. Nat Rev Drug Discov. 2004;3:115–124.
  • You SK, Noh YW, Park HH, et al. Effect of applying modes of the polymer microneedle roller on the permeation of L-ascorbic acid in rats. J Drug Target. 2010;18:15–20.
  • Norman JJ, Arya JM, McClain MA, et al. Microneedle patches: usability and acceptability for self-vaccination against influenza. Vaccine. 2014;32(16):1856–1862.
  • Prausnitz MR. Engineering microneedle patches for vaccination and drug delivery to skin. Annu Rev Chem Biomol Eng. 2017;8:177–200.
  • Birchall JC, Clemo R, Anstey A, et al. Microneedles in clinical practice–an exploratory study into the opinions of healthcare professionals and the public. Pharm Res. 2011;28:95–106.
  • Vicente-Pérez EM, Quinn HL, McAlister E, et al. The use of a pressure-indicating sensor film to provide feedback upon hydrogel-forming microneedle array self-application in vivo. Pharm Res. 2016;33(12):3072–3080.
  • Donnelly RF, Moffatt K, Alkilani AZ, et al. Hydrogel-forming microneedle arrays can be effectively inserted in skin by self-application: a pilot study centred on pharmacist intervention and a patient information leaflet. Pharm Res. 2014;31(8):1989–1999.
  • Mooney K, McElnay JC, Donnelly RF. Children’s views on microneedle use as an alternative to blood sampling for patient monitoring. Int J Pharm Pract. 2014;22:335–344.
  • Ripolin A, Quinn J, Larrañeta E, et al. Successful application of large microneedle patches by human volunteers. Int J Pharm. 2017;521:92–101.
  • Schmier J, Ogden K, Nickman N, et al. Costs of providing infusion therapy for rheumatoid arthritis in a hospital-based infusion center setting. Clin Ther. 2017;39(8):1600–1617.
  • Kim S, Lee J, Shayan FL, et al. KimPhysicochemical study of ascorbic acid 2-glucoside loaded hyaluronic acid dissolving microneedles irradiated by electron beam and gamma ray. Carbohydr Polym. 2018;180:297–303.
  • Barbé B, Gillet P, Beelaert G, et al. Assessment of desiccants and their instructions for use in rapid diagnostic tests. Malar J. 2012;11:326.
  • Lutton RE, Moore J, Larrañeta E, et al. Microneedle characterisation: the need for universal acceptance criteria and GMP specifications when moving towards commercialisation. Drug Deliv Transl Res. 2015;5(4):313–331.
  • Lee K, Jung H. Drawing lithography for microneedles: a review of fundamentals and biomedical applications. Biomaterials. 2012;33:7309–7326.
  • Larrañeta E, McCrudden M, Courtenay A, et al. Microneedles: a new frontier in nanomedicine delivery. Pharm Res. 2016;33:1055–1073.
  • Tuan-Mahmoud T, McCrudden M, Torrisi B, et al. Microneedles for intradermal and transdermal drug delivery. Eur J Pharm Sciences. 2013;50:623–637.
  • Badilescu S, Packirisamy M. BioMEMS: science and engineering perspectives. Boca Raton: CRC Press; 2012.
  • O’Mahony C. Structural characterization and in-vivo reliability evaluation of silicon microneedles. Biomed Microdev. 2014;16:333–343.
  • Quinn HL, Bonham L, Hughes CM, et al. Design of a dissolving microneedle platform for transdermal delivery of a fixed-dose combination of cardiovascular drugs. J Pharm Sci. 2015;104:3490–3500.
  • Dean CH, Alarcon JB, Waterston AM, et al. Cutaneous delivery of a live, attenuated chimeric flavivirus vaccine against Japanese encephalitis (ChimeriVax)-JE) in non- human primates. Hum Vaccin. 2005;1:106–111.
  • So JW, Park HH, Lee SS, et al. Effect of microneedle on the pharmacokinetics of ketoprofen from its transdermal formulations. Drug Delivery. 2009;16(1):52–56.
  • Ita K. Transdermal delivery of drugs with microneedles—potential and challenges. Pharmaceutics. 2015;7:90–105.
  • Adhikari BB, Goodson JL, Chu SY, et al. Assessing the potential cost-effectiveness of microneedle patches in childhood measles vaccination programs: the case for further research and development. Drugs R D. 2016;16:327–338.
  • Lee BY, Bartsch SM, Mvundura M, et al. An economic model assessing the value of microneedle patch delivery of the seasonal influenza vaccine. Vaccine. 2015;33:4727–4736.
  • Lim D-J, Vines JB, Park H, et al. Microneedles: a versatile strategy for transdermal delivery of biological molecules. Int J Biol Macromol. 2017; Accepted Manuscript. DOI:10.1016/j.ijbiomac.2017.12.027
  • Singh A, Yadav S. Microneedling: advances and widening horizons. Ind Derma. 2016;7(4): 244–254. Online J.
  • Jeong HR, Lee HS, Choi IJ, et al. Considerations in the use of microneedles: pain, convenience, anxiety and safety. J Drug Target. 2017;25(1):29–40.
  • Zeng Q, Gammon JM, Tostanoski LH, et al. In vivo expansion of melanoma-specific T cells using microneedle arrays coated with immune-polyelectrolyte multilayers. ACS Biomater Sci Eng. 2017;3:195–205.
  • Wang M, Hu L, Xu C. Recent advances in the design of polymeric microneedles for transdermal drug delivery and biosensing. Lab Chip. 2017;17:1373–1387.
  • Yang S, Wu F, Liu J, et al. Phase-transition microneedle patches for efficient and accurate transdermal delivery of insulin. Adv Funct Mater. 2015;25:4633–4641.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.